The Valley Desk

NCT00040183 · Interventional trial

OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.

Overall registry status Completed

Phase 3

Conditions Pancreatic Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov